Literature DB >> 9858435

Serum testosterone levels are not elevated in patients with ankylosing spondylitis.

E J Giltay1, C Popp-Snijders, D van Schaardenburg, B J Dekker-Saeys, L J Gooren, B A Dijkmans.   

Abstract

OBJECTIVE: Studies in patients with ankylosing spondylitis (AS) describe slightly elevated serum testosterone levels, but these studies were not properly controlled for possible confounders.
METHODS: In a case-control study serum levels of sex steroids, luteinizing hormone, and sex hormone binding globulin (SHGB) were measured in patients with AS and in age and sex matched controls. The body mass index, smoking status, use of alcohol, and fat intake were recorded.
RESULTS: Testosterone levels measured in serum extracts did not differ in 50 male patients with AS compared to controls (mean +/- SD 16 +/- 4 vs 15 +/- 5 nmol/l, respectively; p = 0.54). In unextracted serum, however, male patients showed elevated testosterone (p < 0.001) and dehydroepiandrosterone sulfate levels (p = 0.003), even after controlling for confounders (p < 0.001). One of 10 female patients had an elevated testosterone level in unextracted serum. The 17 male users and one of the 2 female users of phenylbutazone had the highest testosterone levels in unextracted serum, and all showed a significant decline after extraction. Serum levels of other sex steroids, luteinizing hormone, and SHGB did not differ significantly between patients and controls.
CONCLUSION: Serum testosterone levels are not elevated in male patients with AS. Spuriously elevated testosterone levels in unextracted serum might be related to the use of phenylbutazone in our patient sample.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858435

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice.

Authors:  J Capkova; P Ivanyi; Z Rehakova
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

2.  Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis.

Authors:  Abdellah El Maghraoui; Saida Tellal; Souad Chaouir; Khalil Lebbar; Ahmed Bezza; Abderrazak Nouijai; Lahsen Achemlal; Sanaa Bouhssain; El Mostapha Derouiche
Journal:  Clin Rheumatol       Date:  2004-12-08       Impact factor: 2.980

Review 3.  Sex Differences in Pediatric Rheumatology.

Authors:  Marco Cattalini; Martina Soliani; Maria Costanza Caparello; Rolando Cimaz
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

4.  Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis.

Authors:  E J Giltay; D van Schaardenburg; L J Gooren; P J Kostense; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

Review 5.  Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis.

Authors:  Rachael Stovall; Irene E van der Horst-Bruinsma; Shao-Hsien Liu; Tamara Rusman; Lianne S Gensler
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

6.  Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies.

Authors:  M A C van der Weijden; J C van Denderen; W F Lems; M W Heymans; B A C Dijkmans; I E van der Horst-Bruinsma
Journal:  Clin Rheumatol       Date:  2010-08-10       Impact factor: 2.980

Review 7.  Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.

Authors:  T Rusman; R F van Vollenhoven; I E van der Horst-Bruinsma
Journal:  Curr Rheumatol Rep       Date:  2018-05-12       Impact factor: 4.592

8.  Can the Second to Fourth Digit Ratio (2D : 4D) Be a Marker to Determine Ankylosing Spondylitis Disease Activity?

Authors:  Sevcan Uğur; Hasan Fatih Çay; İlhan Sezer; Cahit Kaçar
Journal:  Dis Markers       Date:  2019-02-11       Impact factor: 3.434

9.  Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis.

Authors:  Sungsin Jo; Eun-Ju Lee; Bora Nam; Juyeon Kang; Seunghun Lee; Jeehee Youn; Ye-Soo Park; Yong-Gil Kim; Tae-Hwan Kim
Journal:  Arthritis Res Ther       Date:  2020-05-24       Impact factor: 5.156

10.  Estrogen attenuates the spondyloarthritis manifestations of the SKG arthritis model.

Authors:  Hyemin Jeong; Eun-Kyung Bae; Hunnyun Kim; Yeong Hee Eun; In Young Kim; Hyungjin Kim; Jaejoon Lee; Chan Hong Jeon; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Arthritis Res Ther       Date:  2017-09-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.